A study to evaluate the efficacy of Aragwadha Pushpa Lepa in the management of Vyanga with special reference to Melasma

Phase 2

Not yet recruiting

• Conditions: Chloasma. Ayurveda Condition: VYANGAH,

• Registration Number: CTRI/2022/07/043645
• Lead Sponsor: Sri Sri College of Ayurvedic Science and Research Hospital

Brief Summary

This study is a randomized, open label, parallel group, active controlled trail comparing the efficacy of Aragwadha Pushpa Lepa and Varnya Dashemani Lepa for 30 days in 30 patients with Vyanga (Melasma) that will be conducted at Sri Sri College of Ayurvedic Science and Research, Kanakapura road, Bangalore. Both subjective and objective criteria are used for assessment in the study. This study might reduce the necessity of usage of 10 drugs to using 1 drug in the condition of Vyanga (Melasma).

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-07
• Last Update Posted: 2022-06-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status.

Exclusion Criteria

1. Female on oral contraceptive pills, pregnant women and lactating women 2) Who are on any hormonal therapy 3) Known hyperpigmentation since birth 4) Known inflammatory pigmentation 5) Known malignant melanoma 6) Any other condition interfering with the course of the treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improved uniformity in colour of facial skin	30 days

Secondary Outcome Measures

Name	Time	Method
Reduction in number of hyper pigmented lesions over facial skin	30 days

Trial Locations

Locations (1)

Sri Sri College of Ayurvedic Science and Research Hospital; 🇮🇳 Bangalore, KARNATAKA, India

Sri Sri College of Ayurvedic Science and Research Hospital

🇮🇳Bangalore, KARNATAKA, India

Dr Nanditha M

Principal investigator

9036345368

nandithabhavana@gmail.com